Zhenhu Liu

Dr. Zhenhu Liu

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
ZLZhenhu Liu
Zhenhu Liu
YXYanping Xu
Yanping Xu
LWLing Wu
Ling Wu
SZShicui Zhang
Shicui Zhang
Galanin exerts its biological activities through three different G protein-coupled receptors, Galr1, Galr2 and Galr3. To obtain insights into the evolution of Galrs, we searched the genomes of the deuterostomes by extensive BLAST survey and phylogenetic analyses. The Galr2 and Galr3 share similar genomic structures, and most of them are composed of 2 exons and 1 intron. However, most of Galr1 are composed of 3 extrons and 2 introns. We did not detect the typical Galr genes in the genomic databases of invertebrate deutserotomes, but three Galr1/Alstr homologs and two Galr1/Gpr151 homologs in amphioxus, two Galr1/Gpr151 homologs in sea squirt and one Galr1/Gpr151 homologs in sea urchin were identified. It is highly possible that the Galr genes in vertebrates may evolve from the homologous genes of Galr1/Alstr/Gpr151 in invertebrate deuterostomes. We also proposed that Galr3 genes were the products of Galr2 duplication during evolution, while Galr2 genes may evolve from Galr1.

1 August 2014 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
QHQiaoyan Huang
Qiaoyan Huang
DFDong Feng
Dong Feng
KLKai Liu
Kai Liu
PWPeng Wang
Peng Wang
HXHongyan Xiao
Hongyan Xiao
ZLZhenhu Liu
Zhenhu Liu

1 January 2009 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
CFClaire Fenech
Claire Fenech
LPLila Patrikainen
Lila Patrikainen
DKDaniel S Kerr
Daniel S Kerr
SGSylvie Grall
Sylvie Grall
ZLZhenhu Liu
Zhenhu Liu
JMJean-Pierre Montmayeur
Jean-Pierre Montmayeur
Taste receptors for sweet, bitter and umami tastants are G-protein-coupled receptors (GPCRs). While much effort has been devoted to understanding G-protein-receptor interactions and identifying the components of the signalling cascade downstream of these receptors, at the level of the G-protein the modulation of receptor signal transduction remains relatively unexplored. In this regard a taste-specific regulator of G-protein signaling (RGS), RGS21, has recently been identified. To study whether guanine nucleotide exchange factors (GEFs) are involved in the transduction of the signal downstream of the taste GPCRs we investigated the expression of Ric-8A and Ric-8B in mouse taste cells and their interaction with G-protein subunits found in taste buds. Mammalian Ric-8 proteins were initially identified as potent GEFs for a range of Gα subunits and Ric-8B has recently been shown to amplify olfactory signal transduction. We find that both Ric-8A and Ric-8B are expressed in a large portion of taste bud cells and that most of these cells contain IP3R-3 a marker for sweet, umami and bitter taste receptor cells. Ric-8A interacts with Gα-gustducin and Gαi2 through which it amplifies the signal transduction of hTas2R16, a receptor for bitter compounds. Overall, these findings are consistent with a role for Ric-8 in mammalian taste signal transduction.

1 July 2016 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
KLKai Liu
Kai Liu
YXYanping Xu
Yanping Xu
YWYing Wang
Ying Wang
SWShulei Wei
Shulei Wei
DFDong Feng
Dong Feng
ZLZhenhu Liu
Zhenhu Liu

8 August 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
SZShenjie Zhong
Shenjie Zhong
LCLihui Chen
Lihui Chen
XLXinyi Li
Xinyi Li
XWXinyuan Wang
Xinyuan Wang
GJGuangdong Ji
Guangdong Ji
ZLZhenhu Liu
Zhenhu Liu
The role of bone morphogenetic proteins (BMPs) in regulating adipose has recently become a field of interest. However, the underlying mechanism of this effect has not been elucidated. Here we show that the anti-fat effect of Bmp8a is mediated by promoting fatty acid oxidation and inhibiting adipocyte differentiation. Knocking out the bmp8a gene in zebrafish results in weight gain, fatty liver, and increased fat production. The bmp8a-/- zebrafish exhibits decreased phosphorylation levels of AMPK and ACC in the liver and adipose tissues, indicating reduced fatty acid oxidation. Also, Bmp8a inhibits the differentiation of 3T3-L1 preadipocytes into mature adipocytes by activating the Smad2/3 signaling pathway, in which Smad2/3 binds to the central adipogenic factor PPARγ promoter to inhibit its transcription. In addition, lentivirus-mediated overexpression of Bmp8a in 3T3-L1 cells significantly increases NOD-like receptor, TNF, and NF-κB signaling pathways. Furthermore, NF-κB interacts with PPARγ, blocking PPARγ’s activation of its target gene Fabp4, thereby inhibiting adipocyte differentiation. These data bring a signal bridge between immune regulation and adipocyte differentiation. Collectively, our findings indicate that Bmp8a plays a critical role in regulating lipid metabolism and adipogenesis, potentially providing a therapeutic approach for obesity and its comorbidities.

31 December 2021 in The Lancet Regional Health - Western Pacific
Verified
Journal Article
Open access
HXHong Xiao
Hong Xiao
FLFang Liu
Fang Liu
YHYao He
Yao He
XDXiaochen Dai
Xiaochen Dai
ZLZhenhu Liu
Zhenhu Liu
JUJoseph M. Unger
Joseph M. Unger
The COVID-19 pandemic has had widespread adverse collateral effects on health care delivery for non-COVID-19 disease conditions. Paediatric oncology care is reliant on prompt testing and diagnosis and on timely and coordinated multimodal treatment, all of which have been impacted by the pandemic. This study aimed to quantify the initial and enduring effects of the COVID-19 pandemic on the utilization of paediatric cancer care and to examine whether the pandemic differentially impacted specific demographic groups. We performed an interrupted time series analysis using negative binomial regression to estimate the change in the monthly admissions for paediatric cancer patients (Age 0-17) associated with the COVID-19 pandemic and subsequent lockdown policies. We obtained data from deidentified individual electronic medical records of paediatric cancer inpatients admitted between January 1, 2015 and May 31, 2021 to a tertiary hospital that provides general and specialized healthcare services to an estimated population of 8.4 million in Jining China. Relative risk (RR) estimates representing monthly admissions compared with expected admissions had the pandemic not occurred were derived. The number of inpatient admissions lost due to the pandemic were estimated. The overall denominator for the paediatric population was 1 858 209 individuals in January 2015, which increased to 2 043 803 by May 2021. In total, there were 4 901 admissions for paediatric cancer during the study period, including 1 479 (30%) since February 2020 when the lockdown was implemented. A 33% reduction (95% CI: -43% to -22%) in admissions was observed in February 2020, with the largest relative reduction (-48%, 95% CI: -64% to -24%) among first-time admissions and admissions for patients from rural districts (-46%, 95% CI: -55% to -36%). Admissions quickly rebounded in March 2020 when many government-imposed mobility restrictions were lifted, and continued to resume gradually over time since April 2020, leading to a full recovery as of November 2020. However, the recovery for first-time admissions, and among female patients, younger patients (<5 years) and patients from rural districts was slower over time and incomplete (first-time admissions and rural patients) as of January 2021. The COVID-19 pandemic has had substantial impact on the timely utilization of paediatric oncology services in China, particularly in the early stage of the first wave. Importantly, some population groups were disproportionately affected and the recovery of admissions among those subgroups has been slow and incomplete, warranting targeted approaches to address potentially exacerbated gender and socio-economic inequalities in access to healthcare resources.